Celularity Revenue

In the year 2025, Celularity had annual revenue of $26.55M, down -51.03%. Celularity had revenue of $4.10M in the quarter ending December 31, 2025, a decrease of -77.37%.

Revenue (ttm)

$26.55M

Revenue Growth

-51.03%

P/S Ratio

1.04

Revenue / Employee

$215,854

Employees

123

Market Cap

27.60M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	26.55M	-27.67M	-51.03%
Dec 31, 2024	54.22M	31.45M	138.11%
Dec 31, 2023	22.77M	4.80M	26.68%
Dec 31, 2022	17.98M	-3.36M	-15.75%
Dec 31, 2021	21.34M	7.06M	49.43%
Dec 31, 2020	14.28M	-	-
Dec 31, 2019	-	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

CELU News

1 day ago - Celularity Announces Filing of Form 10-K, Regains Nasdaq Compliance and Highlights Continued Strategic Transformation - GlobeNewsWire
5 days ago - NEXGEL Appoints Ian Blackman as Chief Financial Officer - GlobeNewsWire
11 days ago - Celularity Announces Closing of Transaction with NexGel - GlobeNewsWire
15 days ago - Celularity Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing - GlobeNewsWire
7 weeks ago - Celularity Reiterates Strategic Commercialization Partnership with NEXGEL Focused on Building Biomaterials Franchise with Established Commercial Products and New 510(k) Pathway Product Opportunities - GlobeNewsWire
7 weeks ago - EXCLUSIVE: NexGel To Acquire Regenerative Biomaterial Portfolio From Celularity, Expects To Triple Revenue - Benzinga
7 weeks ago - Celularity Secures $35 Million Strategic License Deal, Strengthens Capital Position to Advance Longevity-Focused Strategy - GlobeNewsWire
2 months ago - Celularity Receives $12.2 Million from Sale of New Jersey Net Operating Losses - GlobeNewsWire

More News